Molecular imaging of Bcr-Abl phosphokinase in a xenograft model

Molecular Cancer Therapeutics

Volumn 8, Issue 3, 2009, Pages 703-710

  Ji, Yuan Wu ^a   Yang, David J ^a   Angelo, Laura S ^a   Kohanim, Saady ^a   Kurzrock, Razelle ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; ETHYLENEDICYSTEINE BCR ABL IN 111; ETHYLENEDICYSTEINE BOVINE SERUM ALBUMIN IN 111; ETHYLENEDICYSTEINE IMMUNOGLOBULIN G1 IN 111; ETHYLENEDICYSTEINE PHOSPHOTYROSINE ANTIBODY IN 111; IMATINIB; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ANTIBODY; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ETHYLENE DICYSTEINE; INDIUM; PHOSPHOTYROSINE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DOWN REGULATION; DRUG MONITORING; DRUG RESPONSE; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKEMIA CELL LINE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR REGRESSION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; DRUG SCREENING; EVALUATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; NUDE MOUSE; PATHOLOGY; RADIOIMMUNOASSAY; SCINTISCANNING; TUMOR VOLUME;

ANIMALS; ANTIBODIES; CYSTEINE; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; INDIUM RADIOISOTOPES; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICE; MICE, NUDE; PHOSPHOTYROSINE; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; RADIOIMMUNODETECTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 66449130945     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0656     Document Type: Article

References (29)

1. Schechter NR, Yang DJ, Azhdarinia A, et al. Assessment of EGF receptors with 99mTc ethylenedicysteine-C225 monoclonal antibody. Anti Cancer Drugs 2003;14:49-56.
2. Kramer-Marek G, Kiesewetter DO, Martiniova L, Jagoda E, Lee SB, Capala J. [(18)F]FBEM-Z (HER2:342)-Affibody molecule - a new molecular tracer for in vivo monitoring of HER2 expression bypositron emission tomography. Eur J Nucl Med Mol Imaging 2008;35:1008-1018
3. Takahashi N, Yang DJ, Kohanim S, et al. Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL. Eur J Nucl Med Mol Imaging 2007;34:354-362 (Pubitemid 46295345)
4. Cai W, Niu G, Chen X. Multimodality imaging of the HER-kinase axis in cancer. Eur J Nucl Med Mol Imaging 2008;35:186-208. (Pubitemid 350234146)
5. Welsher K, Liu Z, Daranciang D, Dai H. Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules. Nano Lett 2008;8:586-590
6. Cai W, Chen X. Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression. Front Biosci 2007;12:4267-4279
7. 124I-labeled small molecular tracer and positron emission tomography. Mol Imaging Biol 2006;8:262-277
8. Gong J, Yang DJ, Kohanim S, Humphreys R, Broemeling L, Kurzrock R. Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies. Mol Cancer Ther 2006;5:2991-3000. (Pubitemid 46092040)
9. Kurzrock R, Shtalrid M, Romero P, et al. c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 1987;325:631-635 (Pubitemid 17055687)
10. Talpaz M, Shah NP, Kantarjian H, et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 2006;354:2531-2541 (Pubitemid 43882349)
11. Druker BJ, Sawyers CL, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001;344:1038-1042 (Pubitemid 32267973)
12. Blondeau P, Berse C, Gravel D. Dimerization of an intermediate during the sodium in liquid ammonia reduction of l-thiazolidine-4-carboxylic acid. Cancer J Chem 1967;45:49-52.
13. Van Nerom CG, Bormans GM, De Roo MJ, Verbruggen AM. First experience in healthyvolunteers with Tc-99m-L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med 1993;20:738-746 (Pubitemid 23315287)
14. Surma MJ, Wiewiora J, Liniecki J. Usefulness of Tc-99m-N,Nethylene-1- dicysteine complex for dynamic kidney investigations. Nucl Med Commun 1994;15:628-635 (Pubitemid 24259776)
15. Ilgan S, Yang DJ, Higuchi T, et al. 99mTc-Ethylenedicysteine-folate: a new tumor imaging agent: synthesis, labeling, and evaluation in animals. Cancer Biother Radiopharm 1998;13:427-435 (Pubitemid 29069839)
16. Zareneyrizi F, Yang DJ, Oh CS, et al. Synthesis of 99mTc ethylenedicysteine colchicine for evaluation of anti-angiogenic effect. Anti Cancer Drugs 1999;10:685-692 (Pubitemid 29450211)
17. Takahashi N, Yang DJ, Kurihara H, et al. Functional imaging of estrogen receptors with radiolabeled-GAP-EDL in rabbit endometriosis model. Acad Radiol 2007;14:1050-1057 (Pubitemid 47248342)
18. Yang D, Yukihiro M, Yu DF, et al. Assessment of therapeutic tumor response using 99mTc-ethylenedicysteine-glucosamine. Cancer Biother Radiopharm 2004;19:443-456 (Pubitemid 39281335)
19. Yang DJ, Kim C-G, Schechter NR, et al. Imaging with 99mTc-EC-DG targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology2003;226:46 5-73.
20. Yang DJ, Azhdarinia A, Wu P, et al. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-Annexin V. Cancer Biother Radiopharm 2001;16:73-83.
21. Yang DJ, Ozaki K, Oh CS, et al. 99mTc-EC-guanine: synthesis, biodistribution, and tumor imaging in animals. Pharmaceutical Res 2005;22:1471-1479 (Pubitemid 41215887)
22. Perera RM, Zoncu R, Johns TG, et al. Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody. Neoplasia 2007;9:1099-1110 (Pubitemid 350255358)
23. Schmidt MM, Thurber GM, Wittrup KD. Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability. Cancer Immunol Immunother 2008. Epub ahead of print.
24. Avignolo C, Bagnasco L, Biasotti B, et al. Internalization via Antennapedia protein transduction domain of an scFv antibodytoward c-Myc protein. FASEB J 2008;22:1237-1245
25. Allhorn M, Olin AI, Nimmerjahn F, Collin M. Human IgG/FccR interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS ONE 2008;3:e1413.
26. Yang DJ, Kim KD, Schechter NR, et al. Assessment of anti-angiogenic effect using 99mTc-EC-endostatin. Cancer Biother Radiopharm 2002;17:233-245 (Pubitemid 34507423)
27. Schechter NR, Wendt RE III, Yang DJ, et al. Radiation dosimetryof 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck. J Nucl Med 2004;45:1683-1687 (Pubitemid 47618475)
28. Fritz J, Vogel W, Bares R, Horger M. Radiologic spectrum of extramedullaryrelapse of myelogenous leukemia in adults. AJR Am J Roentgenol 2007;189:209-218 (Pubitemid 46983213)
29. Cuiffo B, Ren R. Models of hematopoietic malignancies: chronic myeloid leukemia. Drug Discov Today Dis Models 2006;3:183-189 (Pubitemid 44241796)